ACP Journal Club. Review: rosiglitazone increases risk for cardiovascular outcomes and mortality compared with pioglitazone in type 2 diabetes
- PMID: 21844545
- DOI: 10.7326/0003-4819-155-4-201108160-02012
ACP Journal Club. Review: rosiglitazone increases risk for cardiovascular outcomes and mortality compared with pioglitazone in type 2 diabetes
Comment on
-
Comparative cardiovascular effects of thiazolidinediones: systematic review and meta-analysis of observational studies.BMJ. 2011 Mar 17;342:d1309. doi: 10.1136/bmj.d1309. BMJ. 2011. PMID: 21415101 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources